Lab TRIACTIV
Commercial- Indications
- Dry eye disease
Company intelligence / Profile preview
Labtician Ophthalmics commercializes a broad portfolio of advanced surgical devices and therapeutic products for ophthalmology. Their recent launch of the preservative-free artificial tear "Lab TRIACTIV" uses cationic liposomal technology to address all three layers of the tear film for dry eye relief. The company also manufactures silicone scleral buckles used globally in retinal surgeries. They have a strong reputation among Canadian eyecare professionals for regulatory expertise, education, and partnership-driven innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Labtician Ophthalmics.